Could Canopy Growth (TSX:WEED) Stock Be Headed to $5?

Should marijuana investors buy Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) on the dip after losing 65% of its value? Or is the stock going to shed another 75%?

| More on:
question marks written reminders tickets

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Cannabis stocks have been getting clobbered of late, and as negative momentum picks up, losses may exceed the threshold of pain for even the most seasoned of traders. Past corrections to pot stocks have been vicious and unforgiving, but with Canopy Growth (TSX:WEED)(NYSE:CGC) stock now down over 65% from its high, it appears that the curtains are finally closing on the cannabis sector.

So, is this the final pop of the cannabis bubble — or is this sell-off exaggerated beyond proportion?

A dire warning

Just over a year ago, I gave my dire prediction for cannabis stocks after legalization day, urging investors to avoid them like the plague as they hovered near their all-time highs, citing a “sell the news scenario” and the potential for tremendous disappointment due to the continued proliferation of the black market.

Back in February 2018, I warned investors that “the black market may become a major issue,” citing high “cost per gram of legal marijuana” as the primary reason why the black market had the potential to cause a legal weed glut if the cost spread between legal and illegal weed was too large.

While everybody was talking about the cannabis supply shortage that would come with year one of legal marijuana, few noted the possibility that the black market would fulfill the rising demand in the post-legalization era.

It’s tough to quantify the amount of weed being sold in the black market, which is a significant reason why pot investors got burned if they bought right before pot was officially legalized. Many Canadians are legally growing their own plants at home (and likely far too much for a single family to smoke in a year after every harvest).

A disturbing trend

Just a year into nationwide cannabis legalization and the cost spread has grown to the largest it’s ever been. In a recent crowdsourced data compilation conducted by StatsCan, the cost per gram of legal marijuana is almost twice as much as that of illegal marijuana ($10.23 legal vs. $5.59 illegal) as of Q3 2019.

Compared to Q4 2018, the cost per gram of legal weed has actually increased by nearly $0.50, while illegal weed costs decreased by almost $0.80.

Uptrending legal weed costs and down-trending illegal weed costs are a formula for a legal weed glut, and with little to no discussion about the situation in electoral debates, it appears that the spread (and legal weed glut) could get worse before it gets better.

A world of pain up ahead?

The widening cost gap between legal and illegal weed could mean more pain ahead for pot investors. To make the whole situation even uglier, Canopy Growth stock has a double-top technical pattern; should it come to fruition, Canopy’s price target lies in the single digits, at around $5, implying substantial losses for those who attempt to catch the falling knife.

Could Canopy Growth fall to $5?

The technicals seem to indicate such, but that doesn’t necessarily mean that the stock ought to be worth that amount. Personally, I think the sell-off is overextended at this point, given Canopy’s competitive advantages and the long-term growth trajectory.

With no catalysts to stop the bleeding, however, I suspect that Canopy will continue to be the baby that’s thrown out with the bathwater, as investors collectively throw in the towel on pot stocks overall.

If you’re looking to buy the dip at Canopy, make sure to average down your cost basis because the technicals are dire, and at least for now, the fundamentals aren’t going to matter.

Stay hungry. Stay Foolish.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Joey Frenette has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »